BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28224672)

  • 1. PON-P and PON-P2 predictor performance in CAGI challenges: Lessons learned.
    Niroula A; Vihinen M
    Hum Mutat; 2017 Sep; 38(9):1085-1091. PubMed ID: 28224672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are machine learning based methods suited to address complex biological problems? Lessons from CAGI-5 challenges.
    Savojardo C; Babbi G; Bovo S; Capriotti E; Martelli PL; Casadio R
    Hum Mutat; 2019 Sep; 40(9):1455-1462. PubMed ID: 31066146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reports from the fifth edition of CAGI: The Critical Assessment of Genome Interpretation.
    Andreoletti G; Pal LR; Moult J; Brenner SE
    Hum Mutat; 2019 Sep; 40(9):1197-1201. PubMed ID: 31334884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI.
    Carraro M; Minervini G; Giollo M; Bromberg Y; Capriotti E; Casadio R; Dunbrack R; Elefanti L; Fariselli P; Ferrari C; Gough J; Katsonis P; Leonardi E; Lichtarge O; Menin C; Martelli PL; Niroula A; Pal LR; Repo S; Scaini MC; Vihinen M; Wei Q; Xu Q; Yang Y; Yin Y; Zaucha J; Zhao H; Zhou Y; Brenner SE; Moult J; Tosatto SCE
    Hum Mutat; 2017 Sep; 38(9):1042-1050. PubMed ID: 28440912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges.
    Daneshjou R; Wang Y; Bromberg Y; Bovo S; Martelli PL; Babbi G; Lena PD; Casadio R; Edwards M; Gifford D; Jones DT; Sundaram L; Bhat RR; Li X; Pal LR; Kundu K; Yin Y; Moult J; Jiang Y; Pejaver V; Pagel KA; Li B; Mooney SD; Radivojac P; Shah S; Carraro M; Gasparini A; Leonardi E; Giollo M; Ferrari C; Tosatto SCE; Bachar E; Azaria JR; Ofran Y; Unger R; Niroula A; Vihinen M; Chang B; Wang MH; Franke A; Petersen BS; Pirooznia M; Zandi P; McCombie R; Potash JB; Altman RB; Klein TE; Hoskins RA; Repo S; Brenner SE; Morgan AA
    Hum Mutat; 2017 Sep; 38(9):1182-1192. PubMed ID: 28634997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective assessment of the evolutionary action equation for the fitness effect of missense mutations across CAGI-blinded contests.
    Katsonis P; Lichtarge O
    Hum Mutat; 2017 Sep; 38(9):1072-1084. PubMed ID: 28544059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What went wrong with variant effect predictor performance for the PCM1 challenge.
    Miller M; Wang Y; Bromberg Y
    Hum Mutat; 2019 Sep; 40(9):1486-1494. PubMed ID: 31268618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of computational methods for the evaluation of pericentriolar material 1 missense variants in CAGI-5.
    Monzon AM; Carraro M; Chiricosta L; Reggiani F; Han J; Ozturk K; Wang Y; Miller M; Bromberg Y; Capriotti E; Savojardo C; Babbi G; Martelli PL; Casadio R; Katsonis P; Lichtarge O; Carter H; Kousi M; Katsanis N; Andreoletti G; Moult J; Brenner SE; Ferrari C; Leonardi E; Tosatto SCE
    Hum Mutat; 2019 Sep; 40(9):1474-1485. PubMed ID: 31260570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missense variant pathogenicity predictors generalize well across a range of function-specific prediction challenges.
    Pejaver V; Mooney SD; Radivojac P
    Hum Mutat; 2017 Sep; 38(9):1092-1108. PubMed ID: 28508593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing predictions of the impact of variants on splicing in CAGI5.
    Mount SM; Avsec Ž; Carmel L; Casadio R; Çelik MH; Chen K; Cheng J; Cohen NE; Fairbrother WG; Fenesh T; Gagneur J; Gotea V; Holzer T; Lin CF; Martelli PL; Naito T; Nguyen TYD; Savojardo C; Unger R; Wang R; Yang Y; Zhao H
    Hum Mutat; 2019 Sep; 40(9):1215-1224. PubMed ID: 31301154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PON-P2: prediction method for fast and reliable identification of harmful variants.
    Niroula A; Urolagin S; Vihinen M
    PLoS One; 2015; 10(2):e0117380. PubMed ID: 25647319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from the CAGI-4 Hopkins clinical panel challenge.
    Chandonia JM; Adhikari A; Carraro M; Chhibber A; Cutting GR; Fu Y; Gasparini A; Jones DT; Kramer A; Kundu K; Lam HYK; Leonardi E; Moult J; Pal LR; Searls DB; Shah S; Sunyaev S; Tosatto SCE; Yin Y; Buckley BA
    Hum Mutat; 2017 Sep; 38(9):1155-1168. PubMed ID: 28397312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods.
    Critical Assessment of Genome Interpretation Consortium
    Genome Biol; 2024 Feb; 25(1):53. PubMed ID: 38389099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How good are pathogenicity predictors in detecting benign variants?
    Niroula A; Vihinen M
    PLoS Comput Biol; 2019 Feb; 15(2):e1006481. PubMed ID: 30742610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation Interpretation Predictors: Principles, Types, Performance, and Choice.
    Niroula A; Vihinen M
    Hum Mutat; 2016 Jun; 37(6):579-97. PubMed ID: 26987456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blind prediction of deleterious amino acid variations with SNPs&GO.
    Capriotti E; Martelli PL; Fariselli P; Casadio R
    Hum Mutat; 2017 Sep; 38(9):1064-1071. PubMed ID: 28102005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crohn disease risk prediction-Best practices and pitfalls with exome data.
    Giollo M; Jones DT; Carraro M; Leonardi E; Ferrari C; Tosatto SCE
    Hum Mutat; 2017 Sep; 38(9):1193-1200. PubMed ID: 28087895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PON-P: integrated predictor for pathogenicity of missense variants.
    Olatubosun A; Väliaho J; Härkönen J; Thusberg J; Vihinen M
    Hum Mutat; 2012 Aug; 33(8):1166-74. PubMed ID: 22505138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases.
    Kasak L; Hunter JM; Udani R; Bakolitsa C; Hu Z; Adhikari AN; Babbi G; Casadio R; Gough J; Guerrero RF; Jiang Y; Joseph T; Katsonis P; Kotte S; Kundu K; Lichtarge O; Martelli PL; Mooney SD; Moult J; Pal LR; Poitras J; Radivojac P; Rao A; Sivadasan N; Sunderam U; Saipradeep VG; Yin Y; Zaucha J; Brenner SE; Meyn MS
    Hum Mutat; 2019 Sep; 40(9):1373-1391. PubMed ID: 31322791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAGI5: Objective performance assessments of predictions based on the Evolutionary Action equation.
    Katsonis P; Lichtarge O
    Hum Mutat; 2019 Sep; 40(9):1436-1454. PubMed ID: 31317604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.